Alzheimer; News from the web:

Interim results of a clinical trial on an Alzheimer’s vaccine being tested on Down syndrome individuals are promising, say researchers at the Swiss clinical-stage biopharmaceutical company AC Immune. The company’s liposomal therapeutic anti-Abeta vaccine, dubbed ACI-24, is also being evaluated in mild to moderate Alzheimer’s patients in a Phase 2 study.

Read all about it HERE